Want to join the conversation?
On-Premise Software revenues were up 4% for 1Q16 to $5.8Bil, the largest component is software license updates and product support which was up 8% for 1Q16 to $4.7Bil with attach and renewal rates running at their usual high levels. $ORCL expects On-Premise Software business to remain steady.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?